Table 1.
Samples | Gleason score | RecQL4 staining intensity |
Total | ||
---|---|---|---|---|---|
Low | Medium | High | |||
Normal | 7 | 1 | 0 | 8 | |
BPH | 5 | 2 | 0 | 7 | |
PIN | 2 | 2 | 0 | 4 | |
Adenocarcinoma | 2 | 1 | 0 | 0 | 1 |
Adenocarcinoma | 3 | 4 | 3 | 0 | 7 |
Adenocarcinoma | 4 | 3 | 4 | 1 | 8 |
Adenocarcinoma | 5 | 3 | 5 | 2 | 10 |
Adenocarcinoma | 6 | 0 | 6 | 4 | 10 |
Adenocarcinoma | 7 | 3 | 13 | 7 | 23 |
Adenocarcinoma | 8 | 0 | 3 | 5 | 8 |
Adenocarcinoma | 9 | 0 | 7 | 12 | 19 |
Adenocarcinoma | 10 | 0 | 3 | 7 | 10 |
Metastatic | 0 | 0 | 4 | 4 | |
28 | 49 | 42 | 119 | ||
(23.5%) | (41.2%) | (35.3%) |
The data obtained from two prostate tumor tissue arrays (PR951 with 48 core samples and PR751 with 75 core samples) were pooled together. 4 tumor samples in the arrays without any Gleason score were omitted from the analysis. Out of 4 PIN samples, 3 had Gleason grades I, II and III respectively while the 4th sample has Gleason grade between I-II. BPH-Benign prostatic hyperplasia, PIN- Prostatic intraepithelial neoplasias